Chen Zhang

Chen Zhang is a seasoned professional with over seven years of experience in antibody development, biomarker research, and ELISA development. They have held roles as a Senior Scientist and Technology Lead at notable companies, where they specialized in laser capture microdissection (LCM), next generation sequencing (NGS), and quantitative PCR (qPCR). Chen has contributed to establishing new technologies and platforms, including a single cell analysis platform and a semiautomatic mRNA sequencing platform. They hold a PhD in Neuroscience and Obesity from Københavns Universitet, along with other degrees in Biotechnology.